• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析血管通路类型在炎症状态和单核细胞活化中的作用。

Role of the hemodialysis vascular access type in inflammation status and monocyte activation.

作者信息

Colì Luigi, Donati Gabriele, Cappuccilli Maria L, Cianciolo Giuseppe, Comai Giorgia, Cuna Vania, Carretta Elisa, La Manna Gaetano, Stefoni Sergio

机构信息

Nephrology, Dialysis and Renal Transplant Unit, S Orsola University Hospital, Bologna, Italy.

出版信息

Int J Artif Organs. 2011 Jun;34(6):481-8. doi: 10.5301/IJAO.2011.8466.

DOI:10.5301/IJAO.2011.8466
PMID:21725929
Abstract

PURPOSE

The aim of this study was to ascertain the role of different vascular access types in inflammatory status, monocyte activation, and senescence in hemodialysis patients.

METHODS

We recruited 126 hemodialysis patients, including 51 with arterovenous fistula (AVF), 32 with arterovenous graft (AVG), and 43 with tunneled cuffed catheters (TCC). In dialysis patients enrolled in the study and in a control group of 40 healthy subjects, we measured the serum levels of albumin, CRP, IL-6, and TNF-a, the expression of CD14, CD44, and CD32 on monocyte surface, and the percentage of monocytes exhibiting a senescent phenotype (CD14+CD32+).

RESULTS

The patients with AVG compared to those with AVF had: a) higher levels of CRP and TNF-a; b) increased expression of CD14 and CD32 on monocyte surface, with no difference in CD44 expression; c) no difference in the percentage of CD14+CD32+ monocytes. In the comparison of TCC vs. AVF group, we observed significantly higher values of: a) circulating inflammatory markers (CRP, IL-6, TNF-a); b) monocyte surface expression of cellular activation markers (CD14, CD44 and CD32); c) relative count of CD14+CD32+ monocytes. When comparing TCC vs. AVG group, we found: a) no difference in serum levels of CRP, IL-6, and TNF-a; b) no difference in the expression of CD14, CD44, and CD32 on monocyte surface; c) no difference in the percentage of CD14+CD32+ monocytes.

CONCLUSIONS

These results suggest that the use of AVG and TCC for dialysis vascular access is associated with serological and cellular indexes of inflammatory reaction, also resulting in a higher degree of monocyte activation and senescence.

摘要

目的

本研究旨在确定不同血管通路类型在血液透析患者炎症状态、单核细胞活化和衰老中的作用。

方法

我们招募了126名血液透析患者,其中51名使用动静脉内瘘(AVF),32名使用动静脉移植物(AVG),43名使用带隧道带涤纶套导管(TCC)。在纳入研究的透析患者和40名健康受试者的对照组中,我们测量了血清白蛋白、CRP、IL-6和TNF-a水平、单核细胞表面CD14、CD44和CD32的表达,以及表现出衰老表型(CD14+CD32+)的单核细胞百分比。

结果

与AVF患者相比,AVG患者有:a)CRP和TNF-a水平更高;b)单核细胞表面CD14和CD32表达增加,CD44表达无差异;c)CD14+CD32+单核细胞百分比无差异。在TCC与AVF组的比较中,我们观察到以下显著更高的值:a)循环炎症标志物(CRP、IL-6、TNF-a);b)细胞活化标志物(CD14、CD44和CD32)的单核细胞表面表达;c)CD14+CD32+单核细胞的相对计数。在比较TCC与AVG组时,我们发现:a)CRP、IL-6和TNF-a的血清水平无差异;b)单核细胞表面CD14、CD44和CD32的表达无差异;c)CD14+CD32+单核细胞百分比无差异。

结论

这些结果表明,使用AVG和TCC作为透析血管通路与炎症反应的血清学和细胞指标相关,也导致更高程度的单核细胞活化和衰老。

相似文献

1
Role of the hemodialysis vascular access type in inflammation status and monocyte activation.血液透析血管通路类型在炎症状态和单核细胞活化中的作用。
Int J Artif Organs. 2011 Jun;34(6):481-8. doi: 10.5301/IJAO.2011.8466.
2
Association of vascular access type with inflammatory marker levels in maintenance hemodialysis patients.维持性血液透析患者血管通路类型与炎症标志物水平的关联
Semin Dial. 2014 Jul-Aug;27(4):415-23. doi: 10.1111/sdi.12146. Epub 2013 Oct 9.
3
The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients.血管通路的类型会影响慢性血液透析患者的基线炎症状态和促红细胞生成素反应。
Blood Purif. 2006;24(4):387-93. doi: 10.1159/000093681. Epub 2006 Jun 1.
4
Mortality benefits of different hemodialysis access types are age dependent.不同血液透析通路类型的死亡率获益与年龄相关。
J Vasc Surg. 2015 Feb;61(2):449-56. doi: 10.1016/j.jvs.2014.07.091. Epub 2014 Aug 28.
5
Vascular access type and changes in inflammatory markers in incident dialysis patients: a pilot study.新发透析患者的血管通路类型与炎症标志物变化:一项初步研究。
J Vasc Access. 2009 Jul-Sep;10(3):174-9. doi: 10.1177/112972980901000307.
6
Changes in inflammatory markers during a hemodialysis session and their relation to vascular access type.血液透析过程中炎症标志物的变化及其与血管通路类型的关系。
J Vasc Access. 2012 Oct-Dec;13(4):446-51. doi: 10.5301/jva.5000080.
7
Cost-effectiveness analysis of autogenous arteriovenous fistula, arteriovenous graft, and tunneled-cuffed catheter for hemodialysis in patients with end-stage kidney disease in Southern China.中国南方地区终末期肾病患者血液透析自体动静脉内瘘、动静脉移植物和隧道式带袖套导管的成本效果分析。
J Vasc Access. 2024 May;25(3):953-962. doi: 10.1177/11297298221143010. Epub 2022 Dec 20.
8
Cross-talk between inflammation,coagulation/fibrinolysis and vascular access in hemodialysis patients.血液透析患者炎症、凝血/纤维蛋白溶解与血管通路之间的相互作用
J Vasc Access. 2008 Oct-Dec;9(4):248-53.
9
Increased Expression of T Cell Immunoglobulin and Mucin Domain 3 on CD14 Monocytes Is Associated with Systemic Inflammatory Reaction and Brain Injury in Patients with Spontaneous Intracerebral Hemorrhage.CD14单核细胞上T细胞免疫球蛋白和粘蛋白结构域3表达增加与自发性脑出血患者的全身炎症反应及脑损伤相关。
J Stroke Cerebrovasc Dis. 2018 May;27(5):1226-1236. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.041. Epub 2018 Jan 5.
10
Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?血清中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平能否作为长期导管血液透析患者的炎症标志物?
Ren Fail. 2015 Feb;37(1):77-82. doi: 10.3109/0886022X.2014.975133. Epub 2014 Oct 27.

引用本文的文献

1
What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?中性粒细胞胞外诱捕网在与血液透析生物不相容性相关的心血管疾病负担中起什么作用?
Front Med (Lausanne). 2023 Nov 15;10:1268748. doi: 10.3389/fmed.2023.1268748. eCollection 2023.
2
Oxidative stress: An essential factor in the process of arteriovenous fistula failure.氧化应激:动静脉内瘘失败过程中的一个关键因素。
Front Cardiovasc Med. 2022 Aug 11;9:984472. doi: 10.3389/fcvm.2022.984472. eCollection 2022.
3
Influence of Tunneled Hemodialysis-Catheters on Inflammation and Mortality in Dialyzed Patients.
经皮隧道式血液透析导管对透析患者炎症和死亡率的影响。
Int J Environ Res Public Health. 2021 Jul 16;18(14):7605. doi: 10.3390/ijerph18147605.
4
Toxin Removal and Inflammatory State Modulation during Online Hemodiafiltration Using Two Different Dialyzers (TRIAD2 Study).使用两种不同透析器进行在线血液透析滤过时的毒素清除与炎症状态调节(TRIAD2研究)
Methods Protoc. 2021 Apr 22;4(2):26. doi: 10.3390/mps4020026.
5
Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients.静脉铁剂替代治疗可改善血液透析患者的心血管结局。
In Vivo. 2021 May-Jun;35(3):1617-1624. doi: 10.21873/invivo.12419.
6
Monocytes in Uremia.尿毒症中的单核细胞。
Toxins (Basel). 2020 May 21;12(5):340. doi: 10.3390/toxins12050340.
7
Association between initial dialytic modalities and the risks of mortality, infection death, and cardiovascular events: A nationwide population-based cohort study.初始透析模式与死亡率、感染死亡和心血管事件风险的关系:一项全国性基于人群的队列研究。
Sci Rep. 2020 May 15;10(1):8066. doi: 10.1038/s41598-020-64986-2.
8
Immunological Effects of a Single Hemodialysis Treatment.单次血液透析治疗的免疫效应。
Medicina (Kaunas). 2020 Feb 12;56(2):71. doi: 10.3390/medicina56020071.
9
Folic Acid and Vitamin B12 Administration in CKD, Why Not?慢性肾脏病患者的叶酸和维生素 B12 治疗,何乐而不为?
Nutrients. 2019 Feb 13;11(2):383. doi: 10.3390/nu11020383.
10
Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?慢性肾脏病与心血管疾病进展中的叶酸和同型半胱氨酸:何者为先?
Cardiorenal Med. 2017 Oct;7(4):255-266. doi: 10.1159/000471813. Epub 2017 Jun 21.